AXXAM

Event

Discovery & Development US

Michael Campognone, SVP, BD – North America

Axxam at Discovery & Development US 2025

Discovery & Development US 2025, organized by Oxford Global, will take place on October 2–3 in San Diego, California. The event connects leaders from pharma, biotech, and academia to exchange insights on drug discovery, biologics, and formulation & delivery. With focused tracks and high-level discussions, it’s a key meeting point for those driving the next generation of therapeutics.

A conference dedicated to discovery innovation

The two-day conference features expert presentations, interactive sessions, and dedicated networking opportunities designed to accelerate early-stage research and development. By gathering key decision-makers and R&D specialists, Discovery & Development US promotes valuable connections across the discovery and development continuum — from target identification to clinical translation.

Axxam’s contribution to early-stage drug discovery

Representing Axxam, Michael Campognone, our Senior Vice President of Business Development – North America will engage with innovators and potential partners to share how Axxam’s biology-driven discovery platforms can advance new therapeutic programs.
With over 20 years of experience as a Contract Research Organization (CRO), Axxam offers integrated capabilities in target validation, assay development, high-throughput and high-content screening (HTS/HCS), electrophysiology, and iPSC-based assays.

Let’s connect in San Diego

Participation in Discovery & Development US underscores Axxam’s dedication to collaboration, innovation, and partnership.
If you’re attending, we invite you to schedule a meeting with our Business Development team to explore how Axxam can support your discovery journey — from idea to validated lead.

Book a meeting today – Discover how we can empower your next breakthrough in early-stage drug discovery.

 

Scroll to Top